Coverage
-
November 19, 2014
A New Jersey federal judge on Wednesday refused to send 10 consolidated cases alleging injury from Novartis Pharmaceuticals Corp.'s blood pressure medication back to the plaintiffs' home districts, saying that factors in the cases weighed in favor of centralization.
1 other articles on this case.
View all »